Here’s What’s Sending The Indices Higher
A positive durable goods report — the biggest October gain in nine years —
sent the indices higher. A good home sales report didn’t hurt, either. Traders
and investors took the news as a positive sign for economic recovery. Jobless
claims, however, jumped 54,000 last week, indicating a possible delay in
recovery.
The Dow was up 109.88, to 9821.74; the Nasdaq climbed 45.22 to 1933.45; the
S&P 500 rose 11.07 to 1139.59. The
(
$SOX.X |
Quote |
Chart |
News |
PowerRating) was up 4% — that’s up
50% since October 3.
With the Dynegy
(
DYN |
Quote |
Chart |
News |
PowerRating) deal falling through,
(
ENE |
Quote |
Chart |
News |
PowerRating) looks ready to file
for bankruptcy, in what would be the largest ever — surpassing Texaco’s 1987
$35.9 billion case. ENE shares closed at .35. Several companies indicate they
may lose big on the collapse, including JP Morgan Chase
(
JPM |
Quote |
Chart |
News |
PowerRating) up .56
to 38.06; Williams Companies
(
WMB |
Quote |
Chart |
News |
PowerRating), down .05 to 27, and Duke
(
DUK |
Quote |
Chart |
News |
PowerRating), up
.43 to 36.54.
Nvidia
(
NVDA |
Quote |
Chart |
News |
PowerRating) will join the S&P 500, taking Enron’s spot. NVDA was
up 2.25 on the news.
Bookseller Barnes and Noble
(
BKS |
Quote |
Chart |
News |
PowerRating) gapped up after reporting a wider Q3
loss from a year ago. The stock gapped down 36% November 8 after the company
warned that post-September 11 sales were weak. BKS rallied 2.89 to 29.90,
nearing a two-month high.
Brocade
(
BRCD |
Quote |
Chart |
News |
PowerRating) beat estimates, and said their profit may increase in the
current quarter. BRCD was lifted on the news, to 31.70, up 2.88.
Tax preparer H&R Block
(
HRB |
Quote |
Chart |
News |
PowerRating) rose after it raised its profit
forecasts. HRB closed at 40.34 up 4.34.
Freemarkets
(
FMKT |
Quote |
Chart |
News |
PowerRating) spiked 30% after raising their Q4 estimates. FMKT
jumped 4.59 to 18.18.
In a $428 million contract with the U.S. government, BioReliance
(
BREL |
Quote |
Chart |
News |
PowerRating)
will work with Acambis
(
ACAM |
Quote |
Chart |
News |
PowerRating) to make smallpox vaccines. BREL climbed 2.59
to 28.64; ACAM jumped 7.30 to 45.